Browsing: Wellness Tips

Number of Americans Taking Weight Loss Drugs Explodes to Record High Skip to Main ContentU.S. News

A recent Gallup poll reveals a significant increase in the use of GLP-1 medications for weight loss among Americans. As of 2026, 11% of Americans are using these drugs, a notable rise from just 3% in 2024. This surge in usage is linked to a gradual decline in the U.S. adult obesity rate, which has…

A next-generation weight-loss drug being tested by Eli Lilly is showing major results in clinical trials, including a possible added benefit for people with knee osteoarthritis

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free dailyBioPharma Dive newsletter

Adults with obesity and diabetes may benefit more in the long term from undergoing bariatric metabolic surgery than from taking widely popular glucagon-like peptide-1 receptor agonists, according to a new study published in JAMA Network Open

The discussions will cover substances nominated for a range of conditions, from ulcerative colitis and wound healing to obesity, insomnia and opioid withdrawal

Obesity in the U.S. is still on the rise with dangerous implications for the health of millions of Americans, a new study from the American heart Association shows

By SPENCER MACNAUGHTON, ISABEL STOKES, and BELLA SAYEGH | After appearing on the 11th season of “RuPaul’s Drag Race,” the first season of “Canada’s Drag Race: Canada vs. the World,” the sixth season of “RuPaul’s All Stars” and now the 11th season of “All Stars,” Silky Nutmeg Ganache, known by many as the Reverend, is…

Exclusive: Researchers warn of ‘major crisis in male reproductive health’ partly driven by obesity and diabetes

July 7 (Reuters) – The weight-loss drug market is booming, with biotech firms racing to capture a slice of a fast-growing sector dominated by Novo Nordisk and Eli Lilly